Global Neuroscience Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026

The Neuroscience market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Neuroscience market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Neuroscience market. The report focuses on well-known providers in the global Neuroscience industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Neuroscience Industry will develop is also analyzed in detail in Chapter 1.7 of this report.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Neuroscience market covered in Chapter 4:
Johnson & Johnson
Biogen
Novartis Ag
Pfizer Inc.
Lupin Ltd.
Otsuka Holdings Co., Ltd.
Abbvie
Apotex, Inc.
Alkermes Plc
Gedeon Richter Plc
United Therapeutics Corp.
Merck & Co
Daiichi Sankyo Co., Ltd.
Nextsource Biotechnology Llc
Mylan Nv
Boehringer Ingelheim
Sun Pharmaceutical Industries Ltd. (Sun Pharma)
Torrent Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Co.
Lannett Co., Inc.
Dr. Reddy'S Laboratories Ltd.
Sanofi
Eisai Co. Ltd.
Eli Lilly And Co.
Allergan Plc
Alembic Pharmaceuticals Ltd.
Alexza Pharmaceuticals
F. Hoffmann-La Roche Ag
Mallinckrodt
Aurobindo Pharma
Glaxosmithkline Plc
Sumitomo Dainippon Pharma Co., Ltd.
Immunocellular Therapeutics, Ltd.
Autism Therapeutics
Astrazeneca Plc
Acadia Pharmaceuticals, Inc.
UCB SA
Avanir Pharmaceuticals Inc.
H. Lundbeck A/S

In Chapter 11 and 13.3, on the basis of types, the Neuroscience market from 2015 to 2026 is primarily split into:
Anti-Parkinson's Drugs
Alzheimer Disease
Psychotic Disorders
Epileptic Disorders
Autism Spectrum Disorders
Others

In Chapter 12 and 13.4, on the basis of applications, the Neuroscience market from 2015 to 2026 covers:
Hospitals
Diagnostic Laboratories
Research Institutes
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2026